Explainers
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Elixinol Global.
RELATED STOCKHEAD STORIES
Health & Biotech
ScoPo’s Powerplays: ‘Go long equities’ as Nanosonics, Antisense, Volpara to benefit from V-shaped recovery
Health & Biotech
Weed Week: Connecticut and Mexico on board cannabis bandwagon, as Rinehart enters the industry
News
Last Orders: COVID outbreaks weigh on the ASX again
News
Last Orders: ASX finishes up despite investors jumping off Airtasker float
Health & Biotech
Here’s why cannabis M&A activity is on the rise and only just getting started in Australia
Health & Biotech
Elixinol the latest pot stock to M&A; recruits German media entrepreneur to its board
News
Rise and Shine: What you need to know before the ASX opens
News
Trading Places: Which ASX shares have institutional investors been buying over January?
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
10 at 10: These ASX stocks look set to cross the 2020 finish line on a high this morning
News
Trading Places: Perennial Value Management bought over 8pc of the ASX’s only smart homes stock
News
Cannabis stocks take a well-earned breather after days of strong gains
News
Capital Raisings Recap: Another 103 deals and $2.68bn+ raised on the ASX in November
Health & Biotech
StockDoc Podcast: Biden win has medicinal cannabis sector on high, EXL perfectly placed
News
Rise & Shine: What you need to know before the ASX opens
Health & Biotech
Here’s why hemp is a unique opportunity within the cannabis sector; and who’s in it on the ASX
Health & Biotech